The Biosynthesis of DMT

Understanding this is more important than ever in psychedelic research because scientists think DMT may be an endogenous neurotransmitter.


DMT (N,N-dimethyltryptamine) is a naturally occurring psychoactive molecule found in plants of several genera, including Acacia, Desmodium, Mimosa, Virola, Delosperma, Phalaris,1 and citrus.2 DMT is also in the brains of animals including mammals.3,4 Scientists have detected endogenous DMT in humans tissues,5–7 and some hypothesize that DMT may act as a neurotransmitter.1

The Biosynthesis of DMT

In 2018, a paper by Barker reviewed the scholarly literature on DMT, including its biosynthesis.8 Figure 1 illustrates the biosynthesis steps (click to enlarge). It begins with the amino acid tryptophan. Animals must get this amino acid in their diet (i.e., it’s an essential amino acid), whereas plants make it themselves.9

  1. Tryptophan is converted to tryptamine by the enzyme aromatic amino acid decarboxylase (AADC).
  2. Tryptamine undergoes transmethylation by the enzyme indole-N-methyltransferase (INMT). The enzyme takes one methyl group from a compound called S-adenosyl-methionine (SAM) and attaches it to tryptamine (SAM is acting as a cofactor in the reaction by donating the methyl group). The reaction results in tryptamine being converted to N-methyltryptamine (NMT).
  3. Step 2 is repeated, with INMT taking a methyl group from another molecule of SAM, and transferring it to NMT. From this, NMT is converted into N,N-dimethyltryptamine (DMT).

Figure 1: The biosynthesis of DMT 5 (click to enlarge). AACC = aromatic amino acid decarboxylase, INMT = indole-N-methyltransferase, SAM = S-adenosyl-methionine.

Controlling the Biosynthesis of DMT

Things can get out of hand fast if there are no controls on physiological reactions like this in the body. However, it’s not entirely clear at this time how the body regulates DMT production. Figuring it out is complicated by the fact that there may be several forms of INMT (isoenzymes) within a species.8 Since the early 1970s, scientists have reported on an as yet unidentified water soluble and dialyzable inhibitor of INMT which may regulate its activity, and subsequently, DMT biosynthesis.10–14

Continuing Research on DMT

The psychedelic science of DMT is intriguing, important, and provides many paths for research. Barker suggests that “…more research is needed on DMT’s natural role and function and interaction with other neurotransmitter systems.” 8 To that end, he notes the need for removing regulatory blockades that have existed for 50+ years and stymied DMT research. Noting the endogenous nature of DMT and its potential role as a neurotransmitter, he contends that DMT “deserves a special stature for future research.”

Barb Bauer Headshot

Barb is the former Editor and one of the founders of Psychedelic Science Review. She is currently a contributing writer. Her goal is making accurate and concise psychedelic science research assessable so that researchers and private citizens can make informed decisions.


Notify of

Newest Most Voted
Inline Feedbacks
View all comments
Dave Hoare
3 years ago

We need to develop a process for synthesizing DMT utilizing this biosynthetic pathway similar to how psilocybin has been mapped and yeast engineered to produce it in commercially viable yields. 3 enzymes… It should be straight forward.This would help protect threatened species from overharvesting for extraction purposes.

john davis
3 years ago
Reply to  Dave Hoare

ok, but running short of red grass isn’t a possibility as far as I can see

Steven althor
3 years ago

DMT stands out like lsd to be one of the most psychoactive drug on the black market. But no one tries to understand its synthesis like you did here. You actually pointed out the basic behind it but i believe too explicitly on the process that may help the dark net producers and market destroyers.

Christopher Greer Ewing
3 years ago
Reply to  Steven althor

What, how and why? Synth is far more cost and labor intensive than extracting from any one of the number of plants, none of which are threatened and some of which are considered invasive in some locales. ????

1 year ago

This is crazy shit man!

  1. Carbonaro TM, Gatch MB. Neuropharmacology of N,N-Dimethyltryptamine. Brain Res Bull. 2016;126(Pt 1):74-88. doi:10.1016/j.brainresbull.2016.04.016
  2. Servillo L, Giovane A, Balestrieri ML, Cautela D, Castaldo D. N-Methylated Tryptamine Derivatives in Citrus Genus Plants: Identification of N,N,N-Trimethyltryptamine in Bergamot. J Agric Food Chem. 2012;60(37):9512-9518. doi:10.1021/jf302767e
  3. Christian ST, Harrison R, Quayle E, Pagel J, Monti J. The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent. Biochemical Medicine. 1977;18(2):164-183. doi:10.1016/0006-2944(77)90088-6
  4. Saavedra JM, Axelrod J. Psychotomimetic N-Methylated Tryptamines: Formation in Brain in vivo and in vitro. Science. 1972;175(4028):1365-1366. doi:10.1126/science.175.4028.1365
  5. Franzen F, Gross H. Tryptamine, N,N-dimethyltryptamine, N,N-dimethyl-5-hydroxytryptamine and 5-methoxytryptamine in human blood and urine. Nature. 1965;206(988):1052. doi:10.1038/2061052a0
  6. Kärkkäinen J, Forsström T, Tornaeus J, et al. Potentially hallucinogenic 5‐hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues. Scandinavian Journal of Clinical and Laboratory Investigation. 2005;65(3):189-199. doi:10.1080/00365510510013604
  7. Barker SA, McIlhenny EH, Strassman R. A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955–2010. Drug Testing and Analysis. 2012;4(7-8):617-635. doi:10.1002/dta.422
  8. Barker SA. N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function. Front Neurosci. 2018;12. doi:10.3389/fnins.2018.00536
  9. Friedman M. Analysis, Nutrition, and Health Benefits of Tryptophan. Int J Tryptophan Res. 2018;11. doi:10.1177/1178646918802282
  10. Wyatt RJ, Saavedra JM, Axelrod J. A Dimethyltryptamine-Forming Enzyme in Human Blood. AJP. 1973;130(7):754-760. doi:10.1176/ajp.130.7.754
  11. Wyatt RJ, Saavedra JM, Belmaker R, Cohen S, Pollin W. The Dimethyltryptamine-Forming Enzyme in Blood Platelets: A Study in Monozygotic Twins Discordant for Schizophrenia. AJP. 1973;130(12):1359-1361. doi:10.1176/ajp.130.12.1359
  12. Lin R-L, Sargeant S, Narasimhachari N. Indolethylamine-N-methyltransferase in developing rabbit lung. Developmental Psychobiology. 1974;7(5):475-481. doi:10.1002/dev.420070511
  13. Narasimhachari N, Lin RL, Himwich HE. Inhibitor of indolethylamine N-methyltransferase in pineal extract. Res Commun Chem Pathol Pharmacol. 1974;9(2):375-378.
  14. Barker SA, Monti JA, Christian ST. N,N-dimethyltryptamine: An endogenous hallucinogen. International Review of Neurobiology. 1981;22:83–110. doi:10.1016/S0074-7742(08)60291-3